Payment overview · 2025
General Payments
$26.55
1 reported records · 1 companies
Healthcare provider profile · identity verified
Brian T Heimer, MD
Allopathic & Osteopathic Physicians|Family Medicine · NEW ALBANY, IN · NPI 1972597540
Verified facts
What the public records show
CMS Open Payments records show Brian T Heimer, MD received $26.55 in general payments during 2025 across 1 reported records.
Philips North America LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Philips North America LLC | Unresolved — no canonical attribution shown | $26.55 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $26.55 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Holter Normalized: holter |
Device | Philips North America LLC | $26.55 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 513 | 133 |
| Pantoprazole Sodium | Pantoprazole Sodium | 438 | 132 |
| Atorvastatin Calcium | Atorvastatin Calcium | 411 | 119 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 321 | 89 |
| Montelukast Sodium | Montelukast Sodium | 301 | 79 |
| Losartan Potassium | Losartan Potassium | 297 | 88 |
| Amlodipine Besylate | Amlodipine Besylate | 296 | 95 |
| Pravastatin Sodium | Pravastatin Sodium | 251 | 64 |
| Gabapentin | Gabapentin | 230 | 59 |
| Lisinopril | Lisinopril | 229 | 70 |
| Metoprolol Succinate | Metoprolol Succinate | 228 | 68 |
| Omeprazole | Omeprazole | 212 | 61 |
| Clopidogrel | Clopidogrel Bisulfate | 206 | 54 |
| Furosemide | Furosemide | 206 | 58 |
| Glimepiride | Glimepiride | 202 | 62 |
| Metformin Hcl | Metformin Hcl | 201 | 55 |
| Trazodone Hcl | Trazodone Hcl | 200 | 50 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 194 | 54 |
| Escitalopram Oxalate | Escitalopram Oxalate | 192 | 56 |
| Atenolol | Atenolol | 190 | 47 |
| Tamsulosin Hcl | Tamsulosin Hcl | 185 | 57 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 159 | 66 |
| Potassium Chloride | Potassium Chloride | 153 | 46 |
| Meloxicam | Meloxicam | 141 | 41 |
| Eliquis | Apixaban | 138 | 37 |
| Allopurinol | Allopurinol | 132 | 42 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 132 | 23 |
| Prednisone | Prednisone | 129 | 77 |
| Warfarin Sodium | Warfarin Sodium | 129 | 31 |
| Hydrochlorothiazide | Hydrochlorothiazide | 120 | 37 |
| Hydralazine Hcl | Hydralazine Hcl | 117 | 39 |
| Simvastatin | Simvastatin | 102 | 34 |
| Carvedilol | Carvedilol | 97 | 31 |
| Sertraline Hcl | Sertraline Hcl | 93 | 25 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 80 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 78 | 18 |
| Valsartan | Valsartan | 78 | 22 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 77 | 27 |
| Alprazolam | Alprazolam | 75 | 17 |
| Tramadol Hcl | Tramadol Hcl | 75 | 25 |
| Metformin Hcl Er | Metformin Hcl | 74 | 21 |
| Cefuroxime | Cefuroxime Axetil | 72 | 52 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 72 | 57 |
| Metoprolol Tartrate | Metoprolol Tartrate | 70 | 26 |
| Mirtazapine | Mirtazapine | 70 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 69 | 21 |
| Pregabalin | Pregabalin | 68 | 13 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 66 | 20 |
| Ropinirole Hcl | Ropinirole Hcl | 66 | 19 |
| Bumetanide | Bumetanide | 64 | 18 |
| Clonidine Hcl | Clonidine Hcl | 61 | 22 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 58 | 14 |
| Donepezil Hcl | Donepezil Hcl | 58 | 15 |
| Cephalexin | Cephalexin | 55 | 45 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 55 | 37 |
| Famotidine | Famotidine | 55 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 53 | 15 |
| Doxazosin Mesylate | Doxazosin Mesylate | 50 | 18 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 49 | 15 |
| Propranolol Hcl | Propranolol Hcl | 49 | 14 |
| Promethazine Hcl | Promethazine Hcl | 47 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 46 | 12 |
| Irbesartan | Irbesartan | 46 | 16 |
| Nabumetone | Nabumetone | 45 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 45 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 44 | 14 |
| Midodrine Hcl | Midodrine Hcl | 44 | 13 |
| Doxycycline Hyclate | Doxycycline Hyclate | 43 | 37 |
| Spironolactone | Spironolactone | 43 | 16 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 42 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 42 | 13 |
| Bupropion Xl | Bupropion Hcl | 41 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 41 | suppressed |
| Sucralfate | Sucralfate | 41 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 40 | 16 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 38 | 13 |
| Zolpidem Tartrate | Zolpidem Tartrate | 38 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 37 | suppressed |
| Azithromycin | Azithromycin | 37 | 21 |
| Buspirone Hcl | Buspirone Hcl | 37 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 37 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 37 | 13 |
| Synthroid | Levothyroxine Sodium | 37 | 13 |
| Colestipol Hcl | Colestipol Hcl | 36 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 36 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 35 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 34 | suppressed |
| Memantine Hcl | Memantine Hcl | 33 | suppressed |
| Sulindac | Sulindac | 33 | 12 |
| Clonazepam | Clonazepam | 32 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 32 | 22 |
| Amiodarone Hcl | Amiodarone Hcl | 31 | 12 |
| Colesevelam Hcl | Colesevelam Hcl | 31 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 30 | 14 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 30 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 30 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 23 |
| Finasteride | Finasteride | 27 | suppressed |
| Ozempic | Semaglutide | 27 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Jardiance | Empagliflozin | 25 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Xarelto | Rivaroxaban | 24 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 23 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 23 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 23 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Ramipril | Ramipril | 23 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 22 | suppressed |
| Methocarbamol | Methocarbamol | 22 | suppressed |
| Metolazone | Metolazone | 22 | 12 |
| Aripiprazole | Aripiprazole | 21 | suppressed |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Ranolazine Er | Ranolazine | 21 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 20 | suppressed |
| Ciclopirox | Ciclopirox | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 19 | suppressed |
| Fluconazole | Fluconazole | 19 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 19 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Naproxen | Naproxen | 19 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Baclofen | Baclofen | 18 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | 11 |
| Nitroglycerin | Nitroglycerin | 18 | 14 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 17 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 17 | suppressed |
| Myrbetriq | Mirabegron | 17 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Glipizide Er | Glipizide | 16 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 16 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 15 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 15 | suppressed |
| Folic Acid | Folic Acid | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | 13 |
| Nystatin | Nystatin | 15 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 14 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 14 | suppressed |
| Diazepam | Diazepam | 14 | suppressed |
| Humalog Kwikpen U-200 | Insulin Lispro | 14 | suppressed |
| Lorazepam | Lorazepam | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 14 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 13 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Temazepam | Temazepam | 13 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 12 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | 11 |
| Enalapril Maleate | Enalapril Maleate | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $26.55 · 1 records | Philips North America LLC | Holter | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error